$-0.59
(Market cap
$129 Mln
Revenue (TTM)
$31 Mln
P/E Ratio
--
P/B Ratio
9.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.6 %
-
ROCE
-- %
-
Industry P/E
51.35
-
EV/EBITDA
151.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.2
-
Face value
--
-
Shares outstanding
99,628,561
10 Years Aggregate
CFO
$-54.03 Mln
EBITDA
$-93.95 Mln
Net Profit
$-82.60 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Stereotaxis (STXS)
| -42.2 | -- | -28.5 | -48.6 | -4.4 | -32.4 | 0.5 |
|
BSE Sensex*
| -8.3 | 1.2 | 0.2 | -4.6 | 5.5 | 8.1 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Stereotaxis (STXS)
| 0.9 | 30.0 | -15.5 | -66.6 | 21.8 | -3.8 | 389.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Stereotaxis (STXS)
|
1.3 | 128.5 | 31.2 | -21.7 | -69.5 | -139.3 | -- | 9.8 |
| 46.3 | 5,874.3 | 638.8 | -22.7 | 7.4 | -2.8 | -- | 7.5 | |
| 14.4 | 7,749.3 | 6,552.2 | -551.4 | -4.4 | -9.9 | -- | 1.3 | |
| 309.4 | 8,279.3 | 2,589.9 | 168.8 | 10.5 | 2.5 | 51.6 | 1.2 | |
| 61.7 | 9,202.0 | 3,458.5 | -11.6 | 2.2 | -0.6 | -- | 3.9 | |
| 161.7 | 8,935.2 | 551.4 | -189.3 | -34.4 | -26.3 | -- | 13.3 | |
| 100.0 | 6,824.4 | 1,546.2 | 279.0 | 25.4 | 23.9 | 24.8 | 5.6 | |
| 180.0 | 9,423.8 | 1,558.5 | 76.3 | 19.6 | 9.5 | 44.4 | 11.9 | |
| 320.1 | 12,503.5 | 1,454.3 | 171.1 | 14.0 | 12.1 | 72.9 | 8.4 | |
| 141.2 | 7,443.6 | 763.3 | 51.4 | 10.3 | 2.5 | 151.7 | 3.5 |
Shareholding Pattern
View DetailsAbout Stereotaxis (STXS)
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such... as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri. Read more
-
CEO & Chairman
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
-
CEO & Chairman
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
-
Headquarters
Saint Louis, MO
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Stereotaxis (STXS)
What is the current share price of Stereotaxis Inc (STXS) Today?
The share price of Stereotaxis Inc (STXS) is $1.33 (NYSE) as of 29-Jul-2026 16:29 EDT. Stereotaxis Inc (STXS) has given a return of -4.35% in the last 3 years.
What is the current PB & PE ratio of Stereotaxis Inc (STXS)?
Since, TTM earnings of Stereotaxis Inc (STXS) is negative, P/E ratio is not available.
The P/B ratio of Stereotaxis Inc (STXS) is 9.78 times as on 24-Jul-2026, a 186 premium to its peers’ median range of 3.42 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-10.20
|
11.79
|
|
2024
|
-8.23
|
17.32
|
|
2023
|
-6.99
|
6.60
|
|
2022
|
-8.25
|
4.95
|
|
2021
|
-43.86
|
11.92
|
What is the 52 Week High and Low of Stereotaxis Inc (STXS)?
The 52-week high and low of Stereotaxis Inc (STXS) are Rs 3.59 and Rs 1.28 as of 30-Jul-2026.
What is the market cap of Stereotaxis Inc (STXS)?
Stereotaxis Inc (STXS) has a market capitalisation of $ 129 Mln as on 24-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Stereotaxis Inc (STXS)?
Before investing in Stereotaxis Inc (STXS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.